top of page
Microscope

January 27 / 10 AM-7 PM (EST), 8 AM - 5 PM (MST)

Welcome to CUBEC 2024

Canadian Undergraduate Biomedical Engineering Conference

buss_logo.webp

HOSTED BY

UTbiome logo.webp
BMESS logo.webp

JOIN US  /

UNDERGRADUATE RESEARCH PRESENTATIONS/

WHEN

January 27, 2024

ABOUT THE EVENT

CUBEC is a student-led not-for-profit promoting education, inclusion, and awareness in BME industry & research among undergraduates across Canada. 

CUBEC has registered over 400 attendees from 25 universities to listen to over 40 guest speakers, panelists, and professionals. 



 

OUR MISSION /

01

TO PROVIDE A PLATFORM FOR STUDENTS TO NETWORK AND BUILD MEANINGFUL CONNECTION
 

02

TO EXPOSE AND INFORM UNDERGRADUATE BIOMEDICAL ENGINEERING STUDENTS ABOUT INTERNSHIP AND POST GRADUATE OPTIONS ACROSS CANADA.

SPONSORING COMPANIES /
Title Sponsor
Medtronic-Logo.png
Silver Sponsor
Molli_Logo_w_tag.webp
Bronze Sponsor
providence therapeutics logo.png
Bronze Sponsor
Circle_Cardiovascular_Logo.jpg
Bronze Sponsor
abcellera.png
KEYNOTE SPEAKERS  /
Fenster JPG.jpg
Academic Keynote

Dr. Aaron Fenster

Fenster is a Scientist at the Robarts Research Institute, founder and past Director of the Imaging Research Laboratories at the Robarts Research Institute. He is a Professor and Chair of the Division of Imaging Sciences of the Department of Medical Imaging at Western University. He is the founder and past Director of the Graduate Program in Biomedical Engineering and past Director for the Biomedical Imaging Research Centre at Western University. In 2007 he became the Director of the Imaging Program at the Ontario Institute for Cancer Research (OICR). In 2010 he became the Founder and Director of the Centre for Imaging Technology Commercialization– a federally funded Centre of Excellence in Commercialization and Research.

Fenster is a Fellow of seven societies. He held a Canada Research Chair-Tier 1 in Biomedical Engineering from 2000 to 2014. He is the first recipient of the Premier’s (Ontario) Discovery Award for Innovation and Leadership (2007), the Hellmuth Prize for Achievement in Research at Western University (2008), and the Canadian Organization of Medical Physicists Gold Medal Award (2010). In 2011 he was inducted into the Canadian Academy of Health Sciences. In 2013, the International Organization for Medical Physics at its annual meeting named Fenster as one of the 50 international Medical Physicists who have made an outstanding contribution to the advancement of Medical Physics over the past 50 years. In 2020, he received the Order of Ontario for his contribution to the diagnosis and treatment of prostate cancer and in 2022 he was elected to the Royal Society of Canada.

Fenster’s laboratory has been pioneering the development of 3D ultrasound imaging and image-guided interventional systems in radiology, oncology, urology, neonatology, and vascular imaging with some successfully translated into clinical use and to companies (13 licenses to companies). Most recently, his lab has developed 3DUS image-guided interventional systems for prostate biopsy and brachytherapy, breast brachytherapy, and focal liver tumor ablation system. As well, Fenster has developed point of care 3DUS- based diagnostic systems for Successfully translated applications include: 3D transrectal US/MR prostate biopsy, cryosurgery, brachytherapy and breast biopsy; MR-guided focal prostate laser ablation; 3DUS applications for carotid imaging for sensitive monitoring of carotid atherosclerosis and quantification of disease burden; and 3DUS imaging of preterm infants’ brains to assess post hemorrhagic ventricle dilation.
 

stephane moreau medtronic.jpeg
Industry Keynote

Stéphane Moreau

Stéphane Moreau has a bachelor's degree in Physical Engineering (B.Eng.) with a specialization in materials.  He later went on to earn a Master's degree in Applied Sciences (M.Sc.A.) in Biomedical Engineering, specializing in sterilization processes for heat-sensitive biomaterials. Both these degrees were earned at École Polytechnique de Montréal.

 

He also has a Master's degree in Business Administration (MBA) from HEC Montréal, specializing in corporate management concepts and team management.

 

Stéphane has held various management positions in both pharmaceutical and medical instrumentation industries, and has over 23 years' professional experience and involvement in several networks.  Stéphane has also published a number of scientific and managerial articles over the years.

 

Finally, Mr. Moreau is a lecturer at the Université de Montréal (Pharmacy Department), where he teaches Project Management in Drug Development, as well as Regulatory and Technical Aspects of Medical Instrumentation.

 

Mr. Moreau is Senior Director of Engineering, Commercialized Products at Medtronic, and manages a team of 23 engineers, technicians and project managers located in Montreal (Quebec), Mounds View (Minnesota) and Santa Clara (California).

EDITORIAL /
1705068565898.jpeg

3D-Ultrasound Devices, Academia and Entrepreneurship with the Fenster Lab

FEATURED SPEAKERS FROM:

Ubenwa Health.png
SickKids.png
MYO1.png
BlueRock.png
CISSS Logo.png
Robarts Research Logo.png
Neurara.png
cmbes white.png

& MORE!

bottom of page